4-Bromo-6-fluoro-5-iodo-1H-indazole
[CAS# 2765413-93-0]

Identification

• Classification: Organic raw materials >> Heterocyclic compound >> Indazoles
• Name: 4-Bromo-6-fluoro-5-iodo-1H-indazole
• Molecular Formula: C₇H₃BrFIN₂
• Molecular Weight: 340.92
• CAS Registry Number: 2765413-93-0
• SMILES: C1=C2C(=C(C(=C1F)I)Br)C=NN2

Properties

• Density: 2.5±0.1 g/cm³ Calc.^*
• Boiling point: 409.5±40.0 °C 760 mmHg (Calc.)^*
• Flash point: 201.4±27.3 °C (Calc.)^*
• Index of refraction: 1.771 (Calc.)^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Safety Data

• Hazard Symbols: GHS07 Warning
• Risk Statements: H302-H315-H319-H335
• Safety Statements: P261-P280-P301+P312-P302+P352-P305+P351+P338

Discovery and Applications

4-Bromo-6-fluoro-5-iodo-1H-indazole is a halogenated indazole derivative, featuring a bicyclic heterocyclic structure with nitrogen as part of the ring system. Indazole itself is a fused aromatic system consisting of a benzene ring and a pyrrole-like nitrogen-containing heterocycle. In this derivative, the positions 4, 5, and 6 of the benzene ring are substituted with bromine, iodine, and fluorine, respectively. This specific halogenation pattern imparts significant reactivity and influence on the electronic properties of the molecule.

Indazole derivatives are of interest in medicinal chemistry because they often exhibit bioactive properties, including anticancer, antimicrobial, and anti-inflammatory activities. The presence of halogens in the molecule further enriches its potential applications. Bromine, iodine, and fluorine atoms each contribute differently to the molecule's electronic character. Bromine and iodine, being larger and more polarizable, are particularly useful in organic synthesis, especially in metal-catalyzed reactions, where they can act as excellent leaving groups. Fluorine, being highly electronegative, can influence the compound's dipole moment, improve stability, and enhance its bioavailability by modulating lipophilicity.

The synthesis of 4-bromo-6-fluoro-5-iodo-1H-indazole can be achieved through selective halogenation reactions on a suitable indazole precursor. Electrophilic aromatic substitution methods are commonly used for introducing the halogen atoms, often requiring the use of halogenating agents such as iodine monochloride (ICl), N-bromosuccinimide (NBS), or Selectfluor for fluorination. The sequence and regiochemistry of halogenation are crucial, as the electronic effects of pre-existing substituents will guide the orientation of subsequent substitutions.

This compound’s halogenated nature also makes it a valuable intermediate for further functionalization. The positions of the bromine, fluorine, and iodine atoms offer sites for cross-coupling reactions, such as Suzuki, Sonogashira, or Buchwald-Hartwig reactions, allowing the introduction of additional functional groups that can fine-tune the molecule's properties for specific applications. Additionally, the halogens can contribute to increased metabolic stability in drug-like compounds, potentially making this compound a useful scaffold for the design of pharmaceutical agents.

4-Bromo-6-fluoro-5-iodo-1H-indazole, with its distinctive halogen substitutions, is an important intermediate for the synthesis of more complex molecules. It has the potential to be explored further in drug discovery due to its inherent bioactive potential and synthetic versatility.